In agreement with this result the Western blot analysis of lung homogenates (n = 32) showed that Grx1 levels were decreased in COPD when compared to healthy smokers (stage I–II p = 0.045 and stage IV p = 0.022) (Fig 5). This evidence concerns the gene GLRX and chronic obstructive pulmonary disease.